LRRK2 coding variants and the risk of Parkinson’s disease

作者: Julie Lake , Xylena Reed , Rebekah G Langston , Mike A Nalls , Gan-Or Z

DOI: 10.1101/2021.04.22.21255928

关键词:

摘要: Abstract Background The leucine-rich repeat kinase 2 (LRRK2) gene harbors both rare highly damaging missense variants (e.g. p.G2019S) and common non-coding rs76904798) with lower effect sizes that are associated Parkinson’s disease risk. Objectives This study aimed to investigate in a large meta-analysis whether the LRRK2 GWAS signal represented by rs76904798 is independently risk from coding variation, complex linkage disequilibrium structures p.G2019S 5’ haplotype account for association of variants. Methods We performed using imputed genotypes 17,838 cases, 13,404 proxy-cases 173,639 healthy controls European ancestry. excluded carriers and/or clarify role variation mediating risk, relatively assess independence rs76904798. also investigated co-inheritance p.G2019S, p.N2081D. Results remained significantly after excluding p.R1514Q p.N2081D were frequently co-inherited allele distribution p.S1647T changed among cases removing carriers. Conclusions These data suggest previously linked (p.N551K, p.R1398H, p.M1646T p.N2081D) do not drive signal. data, however, preclude independent p.N551K-p.R1398H altered

参考文章(44)
Alexandra I Soto-Ortolaza, Michael G Heckman, Catherine Labbé, Daniel J Serie, Andreas Puschmann, Sruti Rayaprolu, Audrey Strongosky, Magdalena Boczarska-Jedynak, Grzegorz Opala, Anna Krygowska-Wajs, Maria Barcikowska, Krzysztof Czyzewski, Timothy Lynch, Ryan J Uitti, Zbigniew K Wszolek, Owen A Ross, None, GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. American Journal of Neurodegenerative Disease; 2(4), pp 99-287 (2013). ,vol. 2, pp. 287- 299 ,(2013)
Michael G Heckman, Lucia Schottlaender, Alexandra I Soto-Ortolaza, Nancy N Diehl, Sruti Rayaprolu, Kotaro Ogaki, Shinsuke Fujioka, Melissa E Murray, William P Cheshire, Ryan J Uitti, Zbigniew K Wszolek, Matthew J Farrer, Anna Sailer, Andrew B Singleton, Patrick F Chinnery, Michael J Keogh, Steve M Gentleman, Janice L Holton, Kiely Aoife, David MA Mann, Safa Al-Sarraj, Claire Troakes, Dennis W Dickson, Henry Houlden, Owen A Ross, None, LRRK2 exonic variants and risk of multiple system atrophy. Neurology. ,vol. 83, pp. 2256- 2261 ,(2014) , 10.1212/WNL.0000000000001078
Fathima Shaffra Refai, Shin Hui Ng, Eng-King Tan, Evaluating LRRK2 genetic variants with unclear pathogenicity. BioMed Research International. ,vol. 2015, pp. 678701- 678701 ,(2015) , 10.1155/2015/678701
Elisa Greggio, Shushant Jain, Ann Kingsbury, Rina Bandopadhyay, Patrick Lewis, Alice Kaganovich, Marcel P. van der Brug, Alexandra Beilina, Jeff Blackinton, Kelly Jean Thomas, Rili Ahmad, David W. Miller, Sashi Kesavapany, Andrew Singleton, Andrew Lees, Robert J. Harvey, Kirsten Harvey, Mark R. Cookson, Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiology of Disease. ,vol. 23, pp. 329- 341 ,(2006) , 10.1016/J.NBD.2006.04.001
Xi Wu, Ke-Fu Tang, Yang Li, Yu-Yu Xiong, Lu Shen, Zhi-Yun Wei, Ke-Jun Zhou, Jia-Min Niu, Xia Han, Lun Yang, Guo-Yin Feng, Lin He, Sheng-Ying Qin, Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: A meta-analysis Parkinsonism & Related Disorders. ,vol. 18, pp. 722- 730 ,(2012) , 10.1016/J.PARKRELDIS.2012.04.013
Wanli W Smith, Zhong Pei, Haibing Jiang, Valina L Dawson, Ted M Dawson, Christopher A Ross, Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nature Neuroscience. ,vol. 9, pp. 1231- 1233 ,(2006) , 10.1038/NN1776
Daniah Trabzuni, Mina Ryten, Warren Emmett, Adaikalavan Ramasamy, Karl J Lackner, Tanja Zeller, Robert Walker, Colin Smith, Patrick A Lewis, Adamantios Mamais, Rohan de Silva, Jana Vandrovcova, International Parkinson Disease Genomics Consortium (IPDGC), Dena Hernandez, Michael A Nalls, Manu Sharma, Sophie Garnier, Suzanne Lesage, Javier Simon-Sanchez, Thomas Gasser, Peter Heutink, Alexis Brice, Andrew Singleton, Huaibin Cai, Eric Schadt, Nicholas W Wood, Rina Bandopadhyay, Michael E Weale, John Hardy, Vincent Plagnol, None, Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus PLoS ONE. ,vol. 8, pp. e70724- ,(2013) , 10.1371/JOURNAL.PONE.0070724
Owen A Ross, Yih‐Ru Wu, Mei‐Ching Lee, Manabu Funayama, Meng‐Ling Chen, Alexandra I Soto, Ignacio F Mata, Guey‐Jen Lee‐Chen, Chiung Mei Chen, Michelle Tang, Yi Zhao, Nobutaka Hattori, Matthew J Farrer, Eng‐King Tan, Ruey‐Meei Wu, None, Analysis of Lrrk2 R1628P as a Risk Factor for Parkinson's Disease Annals of Neurology. ,vol. 64, pp. 88- 92 ,(2008) , 10.1002/ANA.21405